30
Oct

Cortendo is coming to America. Founded in Sweden, the little biotech has a new CEO who’s building the executive team in the Philadelphia area. And he’s dropping plans for a listing on the Oslo exchange in favor of a U.S. IPO after raising $11 million in bridge financing.

…read more

Source: Little Cortendo gains $11M for late-stage Cushing’s study, hatches U.S. IPO plans

    

0 No comments